000 | 01597 a2200457 4500 | ||
---|---|---|---|
005 | 20250516044002.0 | ||
264 | 0 | _c20110926 | |
008 | 201109s 0 0 rus d | ||
022 | _a0023-1207 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTumanian, S V | |
245 | 0 | 0 |
_a[Antioxidant protection as a component of anesthetic management cancer patients]. _h[electronic resource] |
260 |
_bKhirurgiia _c2011 |
||
300 |
_a66-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdaptation, Physiological _xdrug effects |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnesthetics, Combined _xadministration & dosage |
650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
650 | 0 | 4 |
_aBalanced Anesthesia _xadverse effects |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFlavin Mononucleotide _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInosine Diphosphate _xadministration & dosage |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMonitoring, Physiologic |
650 | 0 | 4 |
_aNeoplasms _xmetabolism |
650 | 0 | 4 | _aNeoplastic Processes |
650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aPerioperative Period |
650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
650 | 0 | 4 |
_aStress, Physiological _xdrug effects |
650 | 0 | 4 |
_aSuccinates _xadministration & dosage |
650 | 0 | 4 |
_aSurgical Procedures, Operative _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aIvanova, L G | |
773 | 0 |
_tKhirurgiia _gno. 6 _gp. 66-9 |
|
999 |
_c20969311 _d20969311 |